Rare cancer share of oncology trial starts
Share of oncology trial starts evaluating medicines for rare cancers.
Unit Percent Industry Healthcare
Records
1
Regions
1
Period
2024
Sources
1
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2024
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global Oncology Trends 2025 | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Rare cancer share of oncology trial starts. Retrieved from https://statorigin.org/indicators/rare-cancer-share-of-oncology-trial-starts